Literature DB >> 15060240

The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician.

Roger Kurlan1, Edward L Kaplan.   

Abstract

Clinicians have been faced with much publicity and contradictory scientific evidence regarding a recently described condition termed pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS). It has been proposed that children with PANDAS experience tics, obsessive-compulsive behavior, and perhaps other neuropsychiatric symptoms as an autoimmune response to streptococcal infection. We review current scientific information and conclude that PANDAS remains a yet-unproven hypothesis. Until more definitive scientific proof is forthcoming, there seems to be insufficient evidence to support 1) routine microbiologic or serologic testing for group A streptococcus in children who present with neuropsychiatric symptoms or 2) the clinical use of antibiotic or immune-modifying therapies in such patients. The optimum diagnostic and therapeutic approach awaits the results of additional research studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060240     DOI: 10.1542/peds.113.4.883

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  31 in total

1.  Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders.

Authors:  Lior Brimberg; Itai Benhar; Adita Mascaro-Blanco; Kathy Alvarez; Dafna Lotan; Christine Winter; Julia Klein; Allon E Moses; Finn E Somnier; James F Leckman; Susan E Swedo; Madeleine W Cunningham; Daphna Joel
Journal:  Neuropsychopharmacology       Date:  2012-04-25       Impact factor: 7.853

2.  Pediatric autoimmune neuropsychiatric disorders associated with streptococcus: comparison of diagnosis and treatment in the community and at a specialty clinic.

Authors:  Vilma Gabbay; Barbara J Coffey; James S Babb; Laura Meyer; Carly Wachtel; Seeba Anam; Beth Rabinovitz
Journal:  Pediatrics       Date:  2008-08       Impact factor: 7.124

Review 3.  Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: an overview.

Authors:  S Esposito; S Bianchini; E Baggi; M Fattizzo; D Rigante
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-24       Impact factor: 3.267

Review 4.  Neuropsychiatric Aspects of Infectious Diseases: An Update.

Authors:  Sahil Munjal; Stephen J Ferrando; Zachary Freyberg
Journal:  Crit Care Clin       Date:  2017-07       Impact factor: 3.598

5.  Identification of pyruvate kinase as an antigen associated with Tourette syndrome.

Authors:  Janice W Kansy; Liliya Katsovich; Kevin S McIver; Jennifer Pick; John B Zabriskie; Paul J Lombroso; James F Leckman; James A Bibb
Journal:  J Neuroimmunol       Date:  2006-10-02       Impact factor: 3.478

Review 6.  A Review and Update on Tourette Syndrome: Where Is the Field Headed?

Authors:  Aysegul Gunduz; Michael S Okun
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

7.  Group cognitive-behavior therapy with family involvement for middle-school-age children with obsessive-compulsive disorder: a pilot study.

Authors:  Jacqueline L Martin; Margo Thienemann
Journal:  Child Psychiatry Hum Dev       Date:  2005

8.  Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.

Authors:  Tanya K Murphy; Eric A Storch; Adam B Lewin; Paula J Edge; Wayne K Goodman
Journal:  J Pediatr       Date:  2011-08-25       Impact factor: 4.406

9.  Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.

Authors:  Jason Tan; Christine H Smith; Ran D Goldman
Journal:  Can Fam Physician       Date:  2012-09       Impact factor: 3.275

Review 10.  Immunopathogenic mechanisms in tourette syndrome: A critical review.

Authors:  Davide Martino; Russell C Dale; Donald L Gilbert; Gavin Giovannoni; James F Leckman
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.